Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Modelling structural determinants of ventilation heterogeneity: A perturbative approach.

Whitfield CA, Horsley A, Jensen OE.

PLoS One. 2018 Nov 29;13(11):e0208049. doi: 10.1371/journal.pone.0208049. eCollection 2018.

2.

Effect of intermittent inspiratory leaks on measurement of lung clearance index using nitrogen and sulfur hexafluoride.

Whitfield CA, Jensen OE, Horsley A.

ERJ Open Res. 2018 Oct 19;4(4). pii: 00132-2018. doi: 10.1183/23120541.00132-2018. eCollection 2018 Oct.

3.

Patterns of regional lung physiology in cystic fibrosis using ventilation magnetic resonance imaging and multiple-breath washout.

Smith LJ, Collier GJ, Marshall H, Hughes PJC, Biancardi AM, Wildman M, Aldag I, West N, Horsley A, Wild JM.

Eur Respir J. 2018 Nov 8;52(5). pii: 1800821. doi: 10.1183/13993003.00821-2018. Print 2018 Nov.

PMID:
30361245
4.

VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

Davies JC, Moskowitz SM, Brown C, Horsley A, Mall MA, McKone EF, Plant BJ, Prais D, Ramsey BW, Taylor-Cousar JL, Tullis E, Uluer A, McKee CM, Robertson S, Shilling RA, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Rowe SM; VX16-659-101 Study Group.

N Engl J Med. 2018 Oct 25;379(17):1599-1611. doi: 10.1056/NEJMoa1807119. Epub 2018 Oct 18.

PMID:
30334693
5.

Feasibility and challenges of using multiple breath washout in COPD.

Bell AS, Lawrence PJ, Singh D, Horsley A.

Int J Chron Obstruct Pulmon Dis. 2018 Jul 10;13:2113-2119. doi: 10.2147/COPD.S164285. eCollection 2018.

6.

Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement.

Robinson PD, Latzin P, Ramsey KA, Stanojevic S, Aurora P, Davis SD, Gappa M, Hall GL, Horsley A, Jensen R, Lum S, Milla C, Nielsen KG, Pittman JE, Rosenfeld M, Singer F, Subbarao P, Gustafsson PM, Ratjen F; ATS Assembly on Pediatrics.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):e1-e19. doi: 10.1164/rccm.201801-0074ST.

PMID:
29493315
7.

Supine posture changes lung volumes and increases ventilation heterogeneity in cystic fibrosis.

Smith LJ, Macleod KA, Collier GJ, Horn FC, Sheridan H, Aldag I, Taylor CJ, Cunningham S, Wild JM, Horsley A.

PLoS One. 2017 Nov 27;12(11):e0188275. doi: 10.1371/journal.pone.0188275. eCollection 2017.

8.

Simple Atomic Quantum Memory Suitable for Semiconductor Quantum Dot Single Photons.

Wolters J, Buser G, Horsley A, Béguin L, Jöckel A, Jahn JP, Warburton RJ, Treutlein P.

Phys Rev Lett. 2017 Aug 11;119(6):060502. doi: 10.1103/PhysRevLett.119.060502. Epub 2017 Aug 8.

PMID:
28949634
9.

Longitudinal Assessment of Children with Mild Cystic Fibrosis Using Hyperpolarized Gas Lung Magnetic Resonance Imaging and Lung Clearance Index.

Smith L, Marshall H, Aldag I, Horn F, Collier G, Hughes D, West N, Horsley A, Taylor CJ, Wild J.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):397-400. doi: 10.1164/rccm.201705-0894LE. No abstract available.

10.

'Our Care through Our Eyes'. Impact of a co-produced digital educational programme on nurses' knowledge, confidence and attitudes in providing care for children and young people who have self-harmed: a mixed-methods study in the UK.

Manning JC, Carter T, Latif A, Horsley A, Cooper J, Armstrong M, Crew J, Wood D, Callaghan P, Wharrad H.

BMJ Open. 2017 May 4;7(4):e014750. doi: 10.1136/bmjopen-2016-014750.

11.

Orkambi in patients with severe disease - Bumps in the road to CFTR modulation.

Horsley A, Barry P.

J Cyst Fibros. 2017 May;16(3):311-312. doi: 10.1016/j.jcf.2017.04.008. Epub 2017 Apr 20. No abstract available.

PMID:
28433526
12.

Detection of early subclinical lung disease in children with cystic fibrosis by lung ventilation imaging with hyperpolarised gas MRI.

Marshall H, Horsley A, Taylor CJ, Smith L, Hughes D, Horn FC, Swift AJ, Parra-Robles J, Hughes PJ, Norquay G, Stewart NJ, Collier GJ, Teare D, Cunningham S, Aldag I, Wild JM.

Thorax. 2017 Aug;72(8):760-762. doi: 10.1136/thoraxjnl-2016-208948. Epub 2017 Mar 6.

13.

Aspergillosis and the role of mucins in cystic fibrosis.

Cowley AC, Thornton DJ, Denning DW, Horsley A.

Pediatr Pulmonol. 2017 Apr;52(4):548-555. doi: 10.1002/ppul.23618. Epub 2016 Nov 21. Review.

14.

Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.

Elborn JS, Horsley A, MacGregor G, Bilton D, Grosswald R, Ahuja S, Springman EB.

Clin Transl Sci. 2017 Jan;10(1):28-34. doi: 10.1111/cts.12428. Epub 2016 Nov 2.

15.

Closed circuit rebreathing to achieve inert gas wash-in for multiple breath wash-out.

Horsley AR, O'Neill K, Downey DG, Elborn JS, Bell NJ, Smith J, Owers-Bradley J.

ERJ Open Res. 2016 Jan 22;2(1). pii: 00042-2015. eCollection 2016 Jan.

16.

Using social media to improve communication with people with cystic fibrosis.

Dale C, Reid N, Cox K, Jones A, Williams H, Shawcross A, Horsley A.

ERJ Open Res. 2016 Mar 29;2(1). pii: 00015-2016. eCollection 2016 Jan.

17.

Challenge for a new era-importance of ensuring accuracy of genotype in cystic fibrosis registries.

Hartley CL, Barry PJ, Green H, Henchliffe J, Brock J, Tobi SE, Ramsden SC, Horsley AR.

J Cyst Fibros. 2016 Sep;15(5):e50-1. doi: 10.1016/j.jcf.2016.03.003. Epub 2016 Apr 9. No abstract available.

18.

Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

Horsley A, Jones AM, Lord R.

Cochrane Database Syst Rev. 2016 Jan 20;(1):CD009529. doi: 10.1002/14651858.CD009529.pub3. Review.

PMID:
26789750
19.

A benchmark survey of the common plants of South Northumberland and Durham, United Kingdom.

Groom QJ, Durkin JL, O'Reilly J, Mclay A, Richards AJ, Angel J, Horsley A, Rogers M, Young G.

Biodivers Data J. 2015 Dec 29;(3):e7318. doi: 10.3897/BDJ.3.e7318. eCollection 2015.

20.

'Our Care through Our Eyes': a mixed-methods, evaluative study of a service-user, co-produced education programme to improve inpatient care of children and young people admitted following self-harm.

Manning JC, Latif A, Carter T, Cooper J, Horsley A, Armstrong M, Wharrad H.

BMJ Open. 2015 Dec 29;5(12):e009680. doi: 10.1136/bmjopen-2015-009680.

21.

Commentaries on Viewpoint: Using the same cut-off for sulfur hexafluoride and nitrogen multiple-breath washout may not be appropriate.

Zuo L, Pannell BK, Horsley A, Bell N, Kane M, Ratjen F, Thompson BR, Nilsen K.

J Appl Physiol (1985). 2015 Dec 15;119(12):1513-4. doi: 10.1152/japplphysiol.00747.2015. No abstract available.

22.

Accurate lung volume measurements in vitro using a novel inert gas washout method suitable for infants.

Shawcross A, Murray CS, Goddard N, Gupta R, Watson S, Horsley A.

Pediatr Pulmonol. 2016 May;51(5):491-7. doi: 10.1002/ppul.23348. Epub 2015 Dec 1.

PMID:
26623550
23.

Ventilation heterogeneity and the benefits and challenges of multiple breath washout testing in patients with cystic fibrosis.

Horsley A, Wild JM.

Paediatr Respir Rev. 2015 Oct;16 Suppl 1:15-8. doi: 10.1016/j.prrv.2015.07.010. Epub 2015 Sep 26. Review.

PMID:
26420586
24.

Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations.

Sonneveld N, Stanojevic S, Amin R, Aurora P, Davies J, Elborn JS, Horsley A, Latzin P, O'Neill K, Robinson P, Scrase E, Selvadurai H, Subbarao P, Welsh L, Yammine S, Ratjen F.

Eur Respir J. 2015 Oct;46(4):1055-64. doi: 10.1183/09031936.00211914. Epub 2015 Jul 9.

25.

Discordance between clinical, physiological, and radiological measures in cystic fibrosis.

Barry PJ, Horsley AR.

Respirol Case Rep. 2014 Dec;2(4):129-31. doi: 10.1002/rcr2.69. Epub 2014 Sep 15.

26.

Putting lung function and physiology into perspective: cystic fibrosis in adults.

Horsley A, Siddiqui S.

Respirology. 2015 Jan;20(1):33-45. doi: 10.1111/resp.12382. Epub 2014 Sep 15. Review.

27.

Enhanced photoacoustic gas analyser response time and impact on accuracy at fast ventilation rates during multiple breath washout.

Horsley A, Macleod K, Gupta R, Goddard N, Bell N.

PLoS One. 2014 Jun 3;9(6):e98487. doi: 10.1371/journal.pone.0098487. eCollection 2014.

28.

Lung clearance index in adults with non-cystic fibrosis bronchiectasis.

Gonem S, Scadding A, Soares M, Singapuri A, Gustafsson P, Ohri C, Range S, Brightling CE, Pavord I, Horsley A, Siddiqui S.

Respir Res. 2014 May 18;15:59. doi: 10.1186/1465-9921-15-59.

29.

What is the importance of classifying Aspergillus disease in cystic fibrosis patients?

Jones AM, Horsley A, Denning DW.

Expert Rev Respir Med. 2014 Aug;8(4):389-92. doi: 10.1586/17476348.2014.915751. Epub 2014 May 29.

PMID:
24869560
30.

Reply: lung clearance index in primary ciliary dyskinesia and bronchiectasis.

Rowan S, Horsley A, Bradley J, Elborn JS.

Am J Respir Crit Care Med. 2014 May 1;189(9):1148-9. doi: 10.1164/rccm.201402-0328LE. No abstract available.

PMID:
24787072
31.

Effects of ivacaftor in patients with cystic fibrosis who carry the G551D mutation and have severe lung disease.

Barry PJ, Plant BJ, Nair A, Bicknell S, Simmonds NJ, Bell NJ, Shafi NT, Daniels T, Shelmerdine S, Felton I, Gunaratnam C, Jones AM, Horsley AR.

Chest. 2014 Jul;146(1):152-158. doi: 10.1378/chest.13-2397.

PMID:
24522694
32.

Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis.

Rowan SA, Bradley JM, Bradbury I, Lawson J, Lynch T, Gustafsson P, Horsley A, O'Neill K, Ennis M, Elborn JS.

Am J Respir Crit Care Med. 2014 Mar 1;189(5):586-92. doi: 10.1164/rccm.201310-1747OC.

PMID:
24428575
33.

Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis.

Horsley A, Rousseau K, Ridley C, Flight W, Jones A, Waigh TA, Thornton DJ.

J Cyst Fibros. 2014 May;13(3):260-6. doi: 10.1016/j.jcf.2013.11.002. Epub 2013 Dec 12.

34.

Sweat chloride is not a useful marker of clinical response to Ivacaftor.

Barry PJ, Jones AM, Webb AK, Horsley AR.

Thorax. 2014 Jun;69(6):586-7. doi: 10.1136/thoraxjnl-2013-204532. Epub 2013 Nov 20.

PMID:
24258833
35.

Evaluation of the impact of alveolar nitrogen excretion on indices derived from multiple breath nitrogen washout.

Nielsen N, Nielsen JG, Horsley AR.

PLoS One. 2013 Sep 9;8(9):e73335. doi: 10.1371/journal.pone.0073335. eCollection 2013.

36.

Author's response: heterogeneity of change in LCI in patients with cystic fibrosis following antibiotic treatment.

Horsley A.

Thorax. 2014 Feb;69(2):184. doi: 10.1136/thoraxjnl-2013-204359. Epub 2013 Sep 5. No abstract available.

PMID:
24008688
37.

Consensus statement for inert gas washout measurement using multiple- and single- breath tests.

Robinson PD, Latzin P, Verbanck S, Hall GL, Horsley A, Gappa M, Thamrin C, Arets HG, Aurora P, Fuchs SI, King GG, Lum S, Macleod K, Paiva M, Pillow JJ, Ranganathan S, Ratjen F, Singer F, Sonnappa S, Stocks J, Subbarao P, Thompson BR, Gustafsson PM.

Eur Respir J. 2013 Mar;41(3):507-22. doi: 10.1183/09031936.00069712. Epub 2013 Feb 8. Erratum in: Eur Respir J. 2013 Nov;42(5):1432. Ranganathan, Sarah [corrected to Ranganathan, Sarath].

38.

Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation.

Horsley AR, Davies JC, Gray RD, Macleod KA, Donovan J, Aziz ZA, Bell NJ, Rainer M, Mt-Isa S, Voase N, Dewar MH, Saunders C, Gibson JS, Parra-Leiton J, Larsen MD, Jeswiet S, Soussi S, Bakar Y, Meister MG, Tyler P, Doherty A, Hansell DM, Ashby D, Hyde SC, Gill DR, Greening AP, Porteous DJ, Innes JA, Boyd AC, Griesenbach U, Cunningham S, Alton EW.

Thorax. 2013 Jun;68(6):532-9. doi: 10.1136/thoraxjnl-2012-202538. Epub 2013 Feb 9.

39.

Itraconazole and inhaled fluticasone causing hypothalamic-pituitary-adrenal axis suppression in adults with cystic fibrosis.

Gilchrist FJ, Cox KJ, Rowe R, Horsley A, Webb AK, Jones AM, Bright-Thomas RJ.

J Cyst Fibros. 2013 Jul;12(4):399-402. doi: 10.1016/j.jcf.2012.10.007. Epub 2012 Dec 28.

40.

Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

Horsley A, Jones AM.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD009529. doi: 10.1002/14651858.CD009529.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;1:CD009529.

PMID:
23076960
41.

A very breathless woman.

Maybury C, Horsley A, Lord R, Bright-Thomas R.

BMJ. 2011 Oct 27;343:d5935. doi: 10.1136/bmj.d5935. No abstract available.

PMID:
22034145
42.

Gout and hyperuricaemia in adults with cystic fibrosis.

Horsley A, Helm J, Brennan A, Bright-Thomas R, Webb K, Jones A.

J R Soc Med. 2011 Jul;104 Suppl 1:S36-9. doi: 10.1258/jrsm.2011.s11106.

43.

Burkholderia latens infection in cystic fibrosis.

Horsley A, Perry C, Martin K, Webb K, Turton J, Kenna D, Jones A.

J Cyst Fibros. 2011 Jul;10(4):291-2. doi: 10.1016/j.jcf.2011.01.001. Epub 2011 Feb 2. No abstract available.

44.

Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?

Horsley A, Webb K, Bright-Thomas R, Govan J, Jones A.

Front Cell Infect Microbiol. 2011 Dec 21;1:18. doi: 10.3389/fcimb.2011.00018. eCollection 2011.

45.

Promoting excellence in children's nursing practice.

Horsley A, Battrick C.

Br J Nurs. 2010 Oct 28-Nov 10;19(19):1213. No abstract available.

PMID:
21042246
46.

Emergency care in Afghanistan.

Horsley A.

Paediatr Nurs. 2009 Sep;21(7):44. No abstract available.

PMID:
19791667
47.

An immunocytochemical assay to detect human CFTR expression following gene transfer.

Davidson H, Wilson A, Gray RD, Horsley A, Pringle IA, McLachlan G, Nairn AC, Stearns C, Gibson J, Holder E, Jones L, Doherty A, Coles R, Sumner-Jones SG, Wasowicz M, Manvell M, Griesenbach U, Hyde SC, Gill DR, Davies J, Collie DD, Alton EW, Porteous DJ, Boyd AC.

Mol Cell Probes. 2009 Dec;23(6):272-80. doi: 10.1016/j.mcp.2009.07.001. Epub 2009 Jul 15.

PMID:
19615439
48.

Three-dimensional reconstruction of the Shigella T3SS transmembrane regions reveals 12-fold symmetry and novel features throughout.

Hodgkinson JL, Horsley A, Stabat D, Simon M, Johnson S, da Fonseca PC, Morris EP, Wall JS, Lea SM, Blocker AJ.

Nat Struct Mol Biol. 2009 May;16(5):477-85. doi: 10.1038/nsmb.1599. Epub 2009 Apr 26. Erratum in: Nat Struct Mol Biol. 2009 Aug;16(8):897.

49.

Lung clearance index in the assessment of airways disease.

Horsley A.

Respir Med. 2009 Jun;103(6):793-9. doi: 10.1016/j.rmed.2009.01.025. Epub 2009 Feb 25. Review.

50.

Ventilation heterogeneity in children with well controlled asthma with normal spirometry indicates residual airways disease.

Macleod KA, Horsley AR, Bell NJ, Greening AP, Innes JA, Cunningham S.

Thorax. 2009 Jan;64(1):33-7. doi: 10.1136/thx.2007.095018. Epub 2008 Aug 4.

PMID:
18678703

Supplemental Content

Loading ...
Support Center